UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dual targeting fixed duration frontline monoclonal antibody therapy for chronic lymphocytic leukemia: A phase 2 study

Leukemia research, 2022-11, Vol.122, p.106945-106945, Article 106945

2022

Volltextzugriff (PDF)

Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group

Journal of clinical oncology, 2005-07, Vol.23 (21), p.4634-4642

2005

Volltextzugriff (PDF)

a Phase 2 Study of Alemtuzumab-Ofatumumab (A+O) Combination in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL)

BLOOD, 2014-12, Vol.124 (21), p.4686-4686

2014

Volltextzugriff (PDF)

A Phase 2 Study of Alemtuzumab-Ofatumumab (A+O) Combination in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) - an Update

BLOOD, 2015-12, Vol.126 (23), p.1734-1734

2015

Volltextzugriff (PDF)

Will radioimmunotherapy replace TBI?

Blood, 2005-10, Vol.106 (8), p.2601-2602

Winter, Jane N.

2005

Volltextzugriff (PDF)

Sphingomyelin/cholesterol liposomal vincristine: a new formulation for an old drug

Expert opinion on biological therapy, 2006-04, Vol.6 (4), p.409-415

2006

Volltextzugriff (PDF)

Hypoxia inducible factor‐alpha activation in lymphoma and relationship to the thioredoxin family

British journal of haematology, 2008-06, Vol.141 (5), p.676-680

2008

Volltextzugriff (PDF)

Radioimmunotherapy and autologous stem cell transplantation for the treatment of B-cell lymphomas

Haematologica (Roma), 2006-01, Vol.91 (1), p.114-120

2006

Volltextzugriff (PDF)

Phase I/II trial of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin's lymphoma

Annals of oncology, 2007-04, Vol.18 (4), p.679-688

2007

Volltextzugriff (PDF)

Targeting CD20

Blood, 2003-06, Vol.101 (11), p.4227-4227

Winter, Jane N.

2003

Volltextzugriff (PDF)

Phase I Study of Fludarabine Plus Cyclophosphamide in Patients With Previously Untreated Low-Grade Lymphoma: Results and and Long-Term Follow-Up—A Report From the Eastern Cooperative Oncology Group

Journal of clinical oncology, 2000-03, Vol.18 (5), p.987-994

2000

Volltextzugriff (PDF)

Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program

Bone marrow transplantation (Basingstoke), 2002-12, Vol.30 (11), p.741-748

2002

Volltextzugriff (PDF)

Treatment Strategies in the Follicular Lymphomas

Oncology research and treatment, 2005-01, Vol.28 (2), p.69-70

Winter, Jane N.

2005

Volltextzugriff (PDF)

The Lactate Issue Revisited: Novel Feeding Protocols To Examine Inhibition of Cell Proliferation and Glucose Metabolism in Hematopoietic Cell Cultures

Biotechnology progress, 2000-09, Vol.16 (5), p.885-892

2000

Volltextzugriff (PDF)

Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2006-03, Vol.37 (6), p.553-557

2006

Volltextzugriff (PDF)

Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2006-06, Vol.37 (11), p.1067-1067

2006

Volltextzugriff (PDF)

Brain protection via cerebral retrograde perfusion during aortic arch aneurysm repair

The Annals of thoracic surgery, 1993-08, Vol.56 (2), p.270-276

1993

Volltextzugriff (PDF)

Ideal or actual body weight to calculate CD34+ cell doses for autologous hematopoietic stem cell transplantation?

Bone marrow transplantation (Basingstoke), 2003-05, Vol.31 (10), p.861-864

2003

Volltextzugriff (PDF)

Prognostic indicators in diffuse, aggressive non-Hodgkin's lymphomas: Regulators of growth fraction and programmed cell death

Seminars in oncology, 1999-10, Vol.26 (5), p.26-33

WINTER, J. N

1999

Volltextzugriff (PDF)

A Phase II Trial of 200% ProMACE-CytaBOM in Patients With Previously Untreated Aggressive Lymphomas: Analysis of Response, Toxicity, and Dose Intensity

Blood, 1999-11, Vol.94 (10), p.3307-3314

1999

Volltextzugriff (PDF)

t(3;21)(q26;q22): A Recurring Chromosomal Abnormality in Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia

Blood, 1990-12, Vol.76 (12), p.2594-2598

1990

Volltextzugriff (PDF)

Multiple unrelated clonal abnormalities in host bone marrow cells after allogeneic stem cell transplantation

Leukemia research, 2004-05, Vol.28 (5), p.537-540

2004

Volltextzugriff (PDF)

High-dose therapy with stem-cell transplantation in the malignant lymphomas

Oncology (Williston Park, N.Y.), 1999-12, Vol.13 (12), p.1635

Winter, J N

1999

Volltextzugriff (PDF)

1 – 25 von 126

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(109)

Publikationsform

Sprache

Englisch
(126)

Erscheinungsjahr

n.n

Thema

Science & Technology
(114)
Life Sciences & Biomedicine
(78)
Humans
(65)
Female
(38)
Biological And Medical Sciences
(36)
Adult
(34)
Medical Sciences
(33)
Male
(32)
Oncology
(28)
Hematology
(27)
Middle Aged
(27)
Technology
(25)
Computer Science
(23)
Computer Science, Theory & Methods
(23)
Aged
(18)
Physical Sciences
(12)
Animals
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)
Hematologic And Hematopoietic Diseases
(10)
Medicin Och Hälsovetenskap
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program

Dual targeting fixed duration frontline monoclonal antibody therapy for chronic lymphocytic leukemia: A phase 2 study

Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group

Clinical Significance of PD-1 and PD-L1 Expression and Ongoing Interaction in the Tumor Microenvironment in Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP

a Phase 2 Study of Alemtuzumab-Ofatumumab (A+O) Combination in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL)

A Phase 2 Study of Alemtuzumab-Ofatumumab (A+O) Combination in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) - an Update

Will radioimmunotherapy replace TBI?

Sphingomyelin/cholesterol liposomal vincristine: a new formulation for an old drug

Hypoxia inducible factor‐alpha activation in lymphoma and relationship to the thioredoxin family

Radioimmunotherapy and autologous stem cell transplantation for the treatment of B-cell lymphomas

Phase I/II trial of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin's lymphoma

Targeting CD20

Phase I Study of Fludarabine Plus Cyclophosphamide in Patients With Previously Untreated Low-Grade Lymphoma: Results and and Long-Term Follow-Up—A Report From the Eastern Cooperative Oncology Group

Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program

Treatment Strategies in the Follicular Lymphomas

The Lactate Issue Revisited: Novel Feeding Protocols To Examine Inhibition of Cell Proliferation and Glucose Metabolism in Hematopoietic Cell Cultures

Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation

Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation

Brain protection via cerebral retrograde perfusion during aortic arch aneurysm repair

Ideal or actual body weight to calculate CD34+ cell doses for autologous hematopoietic stem cell transplantation?

Prognostic indicators in diffuse, aggressive non-Hodgkin's lymphomas: Regulators of growth fraction and programmed cell death

A Phase II Trial of 200% ProMACE-CytaBOM in Patients With Previously Untreated Aggressive Lymphomas: Analysis of Response, Toxicity, and Dose Intensity

t(3;21)(q26;q22): A Recurring Chromosomal Abnormality in Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia

Multiple unrelated clonal abnormalities in host bone marrow cells after allogeneic stem cell transplantation

High-dose therapy with stem-cell transplantation in the malignant lymphomas

Suchergebnisse filtern